Are you considering developing a liposomal drug? InnoMedica is not just a partner but a catalyst for your success. Our expertise and resources can significantly enhance your project's potential, paving the way for a successful partnership.
At InnoMedica, we offer international scientific excellence, acquired through the company's pipeline with two products, TLD-1 (oncology) and TLN-1 (neurology), in advanced clinical trials. Our company is characterised by a modern, modular infrastructure with clean rooms following Good Manufacturing Practice (GMP) requirements. This advanced research and production environment ensures the highest standards in pharmaceutical product development, manufacture and quality assurance, giving you the confidence that your project is in capable hands.
We can advise you and, if required, provide you with operational support in the following areas, among others:
With our in-depth expertise in innovative liposomal nanomedicines and our modern infrastructure, we are ideally equipped to develop innovative solutions to jointly and successfully realise your projects. Flexibility is a core principle of our work. We understand that each project is unique, and we are committed to customising and tailoring our services to your specific needs and requirements, providing you with the reassurance that we will adapt to your project's unique challenges.
If our proposal has piqued your interest, we invite you to take the next step. Please do not hesitate to contact Dr Jonas Zeller, Head of Business Development at InnoMedica, to discuss potential collaboration opportunities. Dr. Jonas Zeller, Head of Business Development von InnoMedica, in Kontakt treten.
jonas.zeller@innomedica.com / +41 (0) 31 311 04 27
